Masy Systems Calibration Laboratory Receives NVLAP Accreditation

Masy Systems Calibration Laboratory Receives NVLAP Accreditation 
 
Masy Systems in Pepperell, Massachusetts is NVLAP accredited for ISO/IEC 17025:2005 (NVLAP Lab Code 200904-0)
 

FOR IMMEDIATE RELEASE

Masy Systems, Inc. - April 29, 2010 - Masy Systems, Inc. is pleased to announce the accreditation of its calibration laboratory in Pepperell, Massachusetts to ISO 17025:2005 by the National Voluntary Laboratory Accreditation Program (NVLAP code 200904-0).

"In receiving NVLAP accreditation, Masy continues to demonstrate its strong commitment to maintaining the highest quality standards and utilizing best practices within the calibration industry" stated Keith Kelly, VP of Quality.

NVLAP, a program administered by the National Institute of Standards and Technology (NIST) and one of the most respected organizations in the world of metrology, performed an independent appraisal of Masy's calibration laboratory and quality management system. NVLAP assessed Masy's calibration competency through onsite audits and proficiency testing, and confirmed Masy met or exceeded all the requirements of the International Organization for Standardization (ISO) standard 17025, General requirements for the competence of testing and calibration laboratories.

Masy Systems, Inc. is one of the leading calibration laboratories in North America specializing in the calibration of temperature measurement devices and validation equipment. Since 1984, Masy Systems has provided quality services for the pharmaceutical, biotech, medical devices and chemical industries. For more information, visit www.masy.com or call 978-433-6279.

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.